Mat Pilates Exercise Program in Patients With Axial Psoriatic Arthritis

Status Enrolling by invitation

Clinical Trial Summary

The aim of this study is to investigate the effectiveness of mat Pilates exercises on spinal mobility, spinal muscle endurance, disease activity, fatigue, emotional well-being, physical performance, and overall quality of life in Psoriatic Arthritis (PsA) patients with axial involvement.

Clinical Trial Description

Psoriasis is a chronic inflammatory skin disease commonly accompanied by joint involvement known as psoriatic arthritis (PsA) [1]. PsA is a subgroup of spondyloarthritis and is characterized by peripheral arthritis, dactylitis, enthesitis and spondylitis. Axial involvement, which occurs in approximately 40% of PsA patients may affect the entire spine, particularly the sacroiliac joint, leading to reduced cervical rotation, lateral flexion and anterior flexion of the spine [2,3]. Exercise interventions in PsA primarily aim to relieve pain, improve mobility and enhance functional capacity [4]. Mat Pilates exercises have been demonstrated as a safe and beneficial intervention in various rheumatic diseases, exhibiting significant improvements in functional status, fatigue, disease activity, pain, and overall quality of life [5-7]. Additionally, Pilates has been reported as effective in maintaining and enhancing spinal mobility [8,9]. However, despite these favorable outcomes, the efficacy of Pilates exercises in PsA remains unexplored. The aim of this study is to investigate the effectiveness of mat pilates exercises in psoriatic arthritis patients with axial involvement. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06176586
Study type	Interventional
Source	Izmir Katip Celebi University
Contact
Status	Enrolling by invitation
Phase	N/A
Start date	January 8, 2024
Completion date	June 10, 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04152759` - Comparative Study to Evaluate the Pharmacokinetics of BAT2506 vs Simponi® in Healthy Subjects	Phase 1
Completed	`NCT03248518` - Lessening the Impact of Fatigue in Inflammatory Rheumatic Diseases	N/A
Completed	`NCT01925768` - Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis	Phase 3
Completed	`NCT01892436` - Extension Study up to 3 Years for Secukinumab in Psoriatic Arthritis	Phase 3
Completed	`NCT01212770` - PALACE 3: Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis	Phase 3
Completed	`NCT05051943` - A Study of the Real-world Use of an Adalimumab Biosimilar and Evaluation of Nutritional Status on the Therapeutic Response
Completed	`NCT01212757` - PALACE 2: Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis	Phase 3
Completed	`NCT03953378` - CD73+ Th1.17 in Rheumatoid Arthritis and Psoriatic Arthritis
Recruiting	`NCT02572700` - Pain Mechanisms and Ultrasonographic Disease Activity in Psoriatic Arthritis
Completed	`NCT02556034` - Assessment of Tender & Swollen Joints Count Score Performed by a Rheumatologist And Rheumatology Nurses in Patients With RA and PsA.
Completed	`NCT02154425` - A Multicenter, Postmarketing Study Evaluating the Concentration of Cimzia® in Mature Breast Milk of Lactating Mothers	Phase 1
Completed	`NCT02188654` - Metformin in Psoriatic Arthritis	N/A
Completed	`NCT01392326` - Efficacy at 24 Weeks and Long Term Safety, Tolerability and Efficacy up to 2 Years of Secukinumab (AIN457) in Patients With Active Psoriatic Arthritis (PsA)	Phase 3
Completed	`NCT02164214` - Does Etanercept Influence Tweak Modulation of Inflammation During Inflammatory Rheumatisms (Psoriatic Arthritis and Rheumatoid Arthritis)?	Phase 3
Completed	`NCT01083693` - Quality of Life Outcomes of HUMIRA in Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA), Ankylosing Spondylitis (AS) After Unsustainable Response to Biologicals and Disease Modifying Antirheumatic Drugs	N/A
Not yet recruiting	`NCT00517101` - Presence of IBD Specific Antibodies (ASCA, ALCA, ACCA, AMCA) in the Sera of Patients With Spondyloarthropathy	N/A
Completed	`NCT00133315` - TNFalfa Blocking Treatment of Spondylarthropathies	Phase 4
Completed	`NCT00659412` - A Placebo-controlled Study With an Extension Examining the Safety and Efficacy of Alefacept in Psoriatic Arthritis	Phase 2
Completed	`NCT00946686` - To Demonstrate the Relative Bioavailability, Parallel Study Of Leflunomide 20 mg Tablets Under Fasting Conditions	Phase 1
Not yet recruiting	`NCT06059430` - Cohort Project of Patients With Inflammatory Rheumatism